← back to search

Sinéad Delany‐Moretlwe

University of Cape Town · ZA
Area of research
Infectious Diseases · General Health Professions
Research interest
Research interests include HIV/AIDS Research and Interventions, Adolescent Sexual and Reproductive Health, Cervical Cancer and HPV Research, and Reproductive tract infections research.
h-index
47
citations
8,718
works
254
NIH funding
primary concept
Medicine
email

Recent publications

The effect of STI screening during pregnancy on vertical transmission of HIV and adverse pregnancy outcomes in South Africa: a modelling study
Journal of the International AIDS Society 2025cited by 6position: middledoi
Safety, tolerability, and acceptability of long-acting injectable cabotegravir for HIV prevention in cisgender female adolescents (HPTN 084-01): a single-arm, open-label, phase 2b trial
The Lancet HIV 2025cited by 6position: middledoi
Features of HIV Infection in the Context of Long-Acting Cabotegravir Preexposure Prophylaxis
New England Journal of Medicine 2024cited by 31position: middledoi
Vaccine value profile for herpes simplex virus
Vaccine 2024cited by 12position: middledoi
Integrating a mental health intervention into PrEP services for South African young women: a human‐centred implementation research approach to intervention development
Journal of the International AIDS Society 2024cited by 11position: lastdoi
Regional and country-level trends in cervical cancer screening coverage in sub-Saharan Africa: A systematic analysis of population-based surveys (2000–2020)
PLoS Medicine 2023cited by 71position: middledoi
Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study
The Lancet HIV 2023cited by 63position: middledoi
A decision support tool has similar high PrEP uptake and increases early PrEP persistence in adolescent girls and young women in South Africa: results from a randomized controlled trial
Journal of the International AIDS Society 2023cited by 22position: lastdoi
The potential benefits of long-acting injectable cabotegravir in pregnant and breastfeeding women and their infants
AIDS 2023cited by 14position: middledoi
Association of naturally acquired type-specific HPV antibodies and subsequent HPV re-detection: systematic review and meta-analysis
Infectious Agents and Cancer 2023cited by 14position: middledoi
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial
The Lancet 2022cited by 522position: firstdoi
PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project
Journal of the International AIDS Society 2022cited by 92position: middledoi
Relative cost-effectiveness of long-acting injectable cabotegravir versus oral pre-exposure prophylaxis in South Africa based on the HPTN 083 and HPTN 084 trials: a modelled economic evaluation and threshold analysis
The Lancet HIV 2022cited by 55position: middledoi
Where are the pregnant and breastfeeding women in new pre-exposure prophylaxis trials? The imperative to overcome the evidence gap
2022cited by 40position: middle
Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World Health Organization consultations, October 2021—March 2022
Vaccine 2022cited by 32position: middledoi
Prevalence and Risk Factors of PrEP Use Stigma Among Adolescent Girls and Young Women in Johannesburg, South Africa and Mwanza, Tanzania Participating in the EMPOWER Trial
AIDS and Behavior 2022cited by 28position: middledoi
Changes in concentrations of cervicovaginal immune mediators across the menstrual cycle: a systematic review and meta-analysis of individual patient data
BMC Medicine 2022cited by 23position: middledoi
The impact of conditional cash transfers for HIV prevention on peer relationships: perspectives from female recipients and non-recipients in HPTN 068
BMC Public Health 2022cited by 1position: middledoi
PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial
PLoS Medicine 2021cited by 175position: lastdoi
Adolescent girls and young women’s PrEP-user journey during an implementation science study in South Africa and Kenya
PLoS ONE 2021cited by 137position: middledoi
Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084
The Journal of Infectious Diseases 2021cited by 69position: middledoi
Diagnostic accuracy of cervical cancer screening and screening–triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study
PLoS Medicine 2021cited by 36position: middledoi
Exploring the feasibility and acceptability of integrating screening for gender-based violence into HIV counselling and testing for adolescent girls and young women in Tanzania and South Africa
BMC Public Health 2021cited by 27position: lastdoi
“You talk about problems until you feel free”: South African adolescent girls’ and young women’s narratives on the value of HIV prevention peer support clubs
BMC Public Health 2020cited by 70position: middledoi
Disclosure of PrEP use by young women in South Africa and Tanzania: qualitative findings from a demonstration project
Culture Health & Sexuality 2020cited by 46position: middledoi
Southern African guidelines on the safe, easy and effective use of pre-exposure prophylaxis: 2020
Southern African Journal of HIV Medicine 2020cited by 44position: middledoi
Cost-Effectiveness of HIV Pre-exposure Prophylaxis Among Heterosexual Men in South Africa: A Cost-Utility Modeling Analysis
JAIDS Journal of Acquired Immune Deficiency Syndromes 2020cited by 29position: middledoi
Performance of the Swede score to predict cervical intraepithelial neoplasia in women with HIV‐1 in Johannesburg, South Africa
International Journal of Gynecology & Obstetrics 2020cited by 1position: middledoi
Human papillomavirus infection and cervical dysplasia in HIV-positive women
AIDS 2019cited by 18position: middledoi
Prevalence and Antimicrobial Resistance of Mycoplasma genitalium Infection Among Women Living With Human Immunodeficiency Virus in South Africa: A Prospective Cohort Study
Clinical Infectious Diseases 2019cited by 13position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Philippe Mayaud · London School of Hygiene & Tropical Medicine19 papers (2013–2023)Admire Chikandiwa · London School of Hygiene & Tropical Medicine16 papers (2013–2021)Helen Kelly · University College Dublin13 papers (2013–2020)Michel Segondy · London School of Hygiene & Tropical Medicine13 papers (2013–2021)Connie Celum · University of Washington10 papers (2012–2024)Bernard Sawadogo · London School of Hygiene & Tropical Medicine10 papers (2013–2021)Linda‐Gail Bekker · Desmond Tutu HIV Foundation8 papers (2013–2022)Jared M. Baeten · University of Washington8 papers (2012–2023)Jean Ngou · London School of Hygiene & Tropical Medicine7 papers (2013–2018)Helen A. Weiss · London School of Hygiene & Tropical Medicine7 papers (2013–2018)Tanvier Omar · London School of Hygiene & Tropical Medicine7 papers (2014–2021)Clare Gilham · London School of Hygiene & Tropical Medicine7 papers (2013–2021)Nicolas Méda · London School of Hygiene & Tropical Medicine7 papers (2014–2023)Jean‐Michel Didelot · London School of Hygiene & Tropical Medicine6 papers (2013–2018) · 6 papers (2013–2019)Saidi Kapiga · London School of Hygiene & Tropical Medicine5 papers (2015–2022)Elizabeth A. Bukusi · University of California, San Francisco5 papers (2015–2022)Sybil Hosek · University of Illinois Chicago5 papers (2013–2025) · 5 papers (2018–2022)Catherine MacPhail · University of Wollongong5 papers (2016–2022)